Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Endo International plc (ENDP)

6.04   -0.14 (-2.27%) 01-17 16:00
Open: 6.19 Pre. Close: 6.18
High: 6.3 Low: 5.92
Volume: 7,156,649 Market Cap: 1370M
Endo International PLC is a generics and specialty branded pharmaceutical company. The company sells generic products in the US which includes pain management, urology, central nervous system disorders, immunosuppression, and oncology and among others.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 6.305 - 6.337 6.337 - 6.357
Low: 5.847 - 5.887 5.887 - 5.913
Close: 5.981 - 6.043 6.043 - 6.083

Technical analysis

as of: 2020-01-17 4:35:45 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 7.39     One year: 8.64
Support: Support1: 5.06    Support2: 4.28
Resistance: Resistance1: 6.33    Resistance2: 7.39
Pivot: 4.90
Moving Average: MA(5): 5.66     MA(20): 4.89
MA(100): 4.23     MA(250): 5.58
MACD: MACD(12,26): 0.28     Signal(9): 0.11
Stochastic oscillator: %K(14,3): 88.32     %D(3): 86.29
RSI: RSI(14): 69.15
52-week: High: 12.49  Low: 1.97  Change(%): -35.0
Average Vol(K): 3-Month: 727260  10-Days: 755109

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
ENDP has closed below upper band by 4.3%. Bollinger Bands are 80.4% wider than normal. The large width of the bands suggest high volatility as compared to ENDP's normal range. The bands have been in this wide range for 1 bars. This is a sign that the current trend might continue.

Headline News

Endo Up on Opioid Abuse Settlement Agreement With Oklahoma
Endo (ENDP) settles an ongoing opioid-abuse litigation issue with the state of Oklahoma for $8.75 million.

Why Is Endo (ENDP) Up 12.3% Since Last Earnings Report?
Endo (ENDP) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  Nasdaq Global Select
Sector:  Healthcare
Industry:  Drug Manufacturers - Specialty Generic
Shares Out. (M) 226.78
Shares Float (M) 167.41
% Held by Insiders 0.81
% Held by Institutions 99.60
Shares Short (K) 31590
Shares Short P. Month (K)

Stock Financials

EPS -2.200
Book Value (p.s.) -2.920
PEG Ratio -0.14
Profit Margin -16.89
Operating Margin 19.55
Return on Assets (ttm) 3.5
Return on Equity (ttm)
Qtrly Rev. Growth -2.2
Gross Profit (p.s.) 6.085
Sales Per Share
EBITDA (p.s.) 0.913
Qtrly Earnings Growth
Operating Cash Flow (M) 189.52
Levered Free Cash Flow (M) 305.29

Stock Valuations

P/E -2.75
P/E Growth Ratio -0.02
P/BV -2.07
P/S 0.46
P/CF 7.23

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.